Recently,BrosMed Medical Co., Ltd. (hereinafter referred to as "BrosMed Medical") announced the completionHundreds of millions of yuan in financing。This round byIDGCapitalLeading investment,Sunshine Ronghui Capital, Mirae Asset andSingularity CapitalCo-investment,StarBridge CapitalAct as the exclusive financial advisor.

BrosMed Medical Co., Ltd.2012Founded in Dongguan Songshan Lake in [Year], it is an internationally renowned multinational medical device group,Focused on the R&D, production, and global sales of high-performance vascular interventional medical devices and therapeutic technologies, it has rapidly grown into a leading enterprise in the field of complex vascular disease treatment.

The company's products have covered multiple fields such as cardiovascular intervention, peripheral vascular intervention, and vascular access.40Multiple product series,Ultra600Zhang holds three types of product registration certificates for domestic and international markets, including those in China, the U.S., Japan, and Europe.100Multiple countries and regions.

Wu Zhipeng from Star Bridge Capital stated"It is a great honor to assist BrosMed Medical in completing this round of financing. With an international strategic layout, excellent product performance, and efficient mass production capabilities, the company has achieved remarkable results in just a few years. We firmly believe that this financing will further consolidate the company's leading position in the industry and continue to lead industrial transformation and technological innovation."